Gilead Sciences (GILD)

With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.

7 Highly Rated Pharmaceutical Stocks for Q4

By Joel Baglole Oct 12, 2020

Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.

10 Undervalued Stocks to Buy

By Will Ashworth, InvestorPlace Contributor Oct 12, 2020

One way to find undervalued stocks is to use free cash flow yield as a barometer. Here are 10 stocks to buy based on this criterion.

7 Biotech Stocks To Buy For Profit From The Vaccine Crunch

By Tezcan Gecgil, InvestorPlace Contributor Oct 7, 2020

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.

5 Top Stock Trades for Friday: PINS, CROX, STZ, CAG, GILD

By Bret Kenwell, InvestorPlace Contributor Oct 1, 2020

Pinterest, Crocs, Gilead Sciences, Constellation Brands and ConAgra Foods were our top stock trades from Thursday.

Merger Mania: 4 Major Deals to Watch

By Louis Navellier, Editor, Growth Investor Sep 16, 2020

It’s an exciting time for mergers and acquisitions in some of the hottest sectors -- including software, cloud services, artificial intelligence and health care. Here are four major mergers to watch.

Immunomedics News: IMMU Stock Skyrockets 99% on Gilead Deal

By William White, InvestorPlace Writer Sep 14, 2020

Immunomedics (IMMU) is seeing IMMU stock soar higher Monday following news that it will be acquired by Gilead (GILD) for $21 billion.

5 of the Best Pharmaceutical Stocks to Buy Right Now

By David Moadel, InvestorPlace Contributor Sep 10, 2020

A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.

4 Pharmaceutical Stocks With Deep Pipelines

By Larry Ramer, InvestorPlace Contributor Sep 2, 2020

Coronavirus vaccines get all the attention, but these four pharmaceutical stocks benefit from equipment, drug and test kit developments.

What Happened to Gilead Sciences and Is the Stock Still a Buy?

By Matt McCall and the InvestorPlace Research Staff, Editor, MoneyWire Aug 31, 2020

Gilead stock has been under pressure for a few months, giving investors a great risk/reward setup, especially with its coronavirus treatment.

Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally

By Larry Ramer, InvestorPlace Contributor Aug 28, 2020

Strong sales of Gilead's successful novel coronavirus drug, remdesivir, will ultimately lift GILD stock and reward shareholders.

30 Dividend Stocks to Buy Now for 20 Years of Income Growth

By Josh Enomoto, InvestorPlace Contributor Aug 26, 2020

With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.

4 Coronavirus Stocks to Buy as the Pandemic Rages On

By Faisal Humayun Aug 3, 2020

As the pandemic continues to grow, these four coronavirus stocks are great ways to protect your portfolio for the foreseeable future.

Quick Income from a Put Write on Johnson & Johnson

By Ken Trester Jul 14, 2020

Earnings season is upon us, and Johnson & Johnson (NYSE:JNJ) will kick off second-quarter reporting for the big pharmaceutical stocks on July 16.

4 Pharmaceutical Stocks to Watch for the Rest of 2020

By Faisal Humayun Jul 7, 2020

As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.

10 Stocks Riding on the Covid-19 Recovery

By Josh Enomoto, InvestorPlace Contributor Jun 23, 2020

With pandemic fears shuttering many economies, most investments have cratered. However, a small group of coronavirus stocks may offer significant upside potential.

Navellier Ratings

Total Grade

Hold

Gilead Sciences (GILD)

GILD Stock Predictions, Articles, and Gilead Sciences News

Navellier Ratings

Total Grade

Subscriber Sign in